Takeaways from the most recent news in the technology and policies shaping healthcare.
Insurers and the rules of getting paid: coverage, prior authorization, claims, denials, and the friction between health plans and the providers they reimburse.
A federal judge dismissed Ballad Health's Medicare Advantage lawsuit against UnitedHealth, ordering the payment dispute into arbitration.
Why it matters: Arbitration clauses in payer contracts can quietly steer provider-insurer disputes out of court, shaping how health systems fight Medicare Advantage denials.
Medicare Advantage plans are refocusing on the post-discharge period to reduce readmissions and protect Star Ratings.
Why it matters: Star Ratings drive billions in bonus payments and enrollment, and better care transitions are becoming a key way plans defend those scores.
KFF Health News details how vertical integration across hospitals, insurers, and pharmacies steers patients toward higher-priced care and inflates their bills.
Why it matters: As a handful of integrated companies control care, coverage, and drugs, patients face higher costs with little visibility into why.
Walmart will send employees to 17 health systems in 2026 for complex care through its Centers of Excellence program, covering treatment and travel at no cost.
Why it matters: As one of the largest U.S. employers, Walmart's decision to steer workers to vetted providers pressures health systems to prove quality and reshapes how expensive care gets purchased.
UnitedHealth Group is facing an IRS probe into transfers involving foreign subsidiaries that may have lowered its US taxes, STAT News reports.
Why it matters: A tax dispute at the largest US health insurer could add to mounting financial and regulatory pressure on a company central to the healthcare system.
Medicare Advantage plans are treating the first 24 hours after hospital discharge as a make-or-break window for reducing readmissions and defending their star ratings.
Why it matters: Star ratings drive billions in CMS bonus payments and member enrollment, making post-discharge care a direct lever on plan revenue.
Providence will fully exit the insurance business, shutting down Providence Health Plan after a Medicare Advantage deal with a national insurer fell through.
Why it matters: It underscores how hard Medicare Advantage economics have become, pushing even large health systems out of owning insurance plans.
CVS Caremark named 25-year company veteran Keith Reynolds as chief growth officer as Chief Sales Officer Jim Fowler retires.
Why it matters: CVS Caremark is one of the largest PBMs in the US, and its growth strategy shapes drug costs for millions as regulators scrutinize the industry.
A year after HR 1, Medicaid faces looming eligibility checks and work requirements, with six states serving as bellwethers for coverage and financial impact.
Why it matters: Medicaid churn drives uncompensated care and margin pressure for hospitals while reshaping insurer enrollment ahead of 2027 rule changes.
UnitedHealthcare is adding reimbursement limits on five lab test categories across its major plan lines, with most policies effective Sept. 1.
Why it matters: New payer limits mean more denials and documentation burden for labs and physicians ordering these tests.
A handful of insurers are exiting or scaling back Medicare Advantage markets as rising medical costs, federal cuts, and star-rating disputes pressure profits.
Why it matters: Insurer pullbacks mean fewer plan choices for seniors and shifting payer dynamics for hospitals and medical groups.
Providers win the vast majority of No Surprises Act arbitration cases, pushing health plans to fix out-of-network claims before they reach costly IDR.
Why it matters: Losing 88% of arbitration cases makes out-of-network claims a persistent, avoidable cost driver for health plans.
AI detection tools have matured enough to catch the more than $100 billion in annual U.S. healthcare fraud, shifting the challenge from technology to adoption.
Why it matters: Fraud, waste, and abuse inflate costs across the entire system, and proactive AI detection could finally recover dollars that reactive audits never touched.
Cigna CEO Brian Evanko says insurers back surprise-billing protections but see clear abuses of the No Surprises Act's arbitration system, joining a growing payer pushback.
Why it matters: How the arbitration fight is resolved will shape out-of-network reimbursement and the balance of power between insurers and providers.
Humana will exit Medicare Advantage plans covering about 600,000 members in 2027 as it prioritizes margin recovery, aiming to retain a portion of that volume.
Why it matters: Humana's retreat signals that major insurers are shrinking unprofitable Medicare Advantage plans, disrupting coverage for members and payer mix for providers.
Providence, Carle Health and Michigan Medicine are winding down owned insurance plans, testing whether provider-sponsored health plans can survive.
Why it matters: Owning a health plan was pitched as the future of integrated care, but the recent closures show the strategy carries real financial risk for providers.
The lapse of ACA enhanced premium tax credits is boosting some insurers' margins while pushing more uninsured patients onto hospitals.
Why it matters: The subsidy cliff is splitting the industry, rewarding payers with a leaner risk pool while saddling hospitals with rising uncompensated care.
Big payers continue expanding into health services, but they are getting more selective about which bets to keep and which to unwind.
Why it matters: How insurers diversify into care delivery reshapes competition, margins, and the boundary between coverage and care for the entire industry.
A MedCity News Bullseye panel argued that rising U.S. drug spending is not improving patient access, and that pricing transparency and PBM reform are needed to fix it.
Why it matters: Rising drug spend without better access signals a broken pricing system that transparency reforms could realign toward patients.
Second-quarter earnings show the largest U.S. insurers leaning harder on services units as tightening insurance margins push them beyond core coverage.
Why it matters: As payers become diversified healthcare conglomerates, their control over pharmacies, clinics and data reshapes competition and care across the industry.